Veeva Systems

Veeva Systems
Name	Veeva Systems
Type	Public
Industry	Software
Founded	2007
Founders	Peter Gassner
Headquarters	Pleasanton, California
Area served	Global
Products	Cloud-based software for pharmaceutical industry, biotechnology, life sciences
Revenue	(see Financial Performance)
Website	(not displayed)

Veeva Systems is a publicly traded provider of cloud-based software and services focused on the pharmaceutical industry, biotechnology, and life sciences sectors. The company develops industry-specific applications for clinical trials, regulatory affairs, quality management, and commercial operations, positioning itself among enterprise vendors serving regulated healthcare markets. Veeva’s trajectory intersects with major industry stakeholders such as Pfizer, Johnson & Johnson, Novartis, Roche, and Merck & Co..

History

Veeva Systems was founded in 2007 by Peter Gassner with early backing from investors connected to Salesforce.com and Sequoia Capital. In its formative years the company adopted a software-as-a-service model influenced by platforms like Salesforce. Veeva expanded through customer adoption by global pharmaceutical firms including AstraZeneca, GlaxoSmithKline, and Sanofi. The firm completed an initial public offering in 2013 on the NASDAQ exchange, joining cohorts of enterprise cloud companies such as Workday, ServiceNow, and Okta. Growth continued via product development and strategic hires from companies such as Oracle Corporation and SAP SE. Over time, Veeva pursued international expansion into markets that include the European Union, Japan, and China, aligning with multinational regulatory regimes like the U.S. Food and Drug Administration and the European Medicines Agency.

Products and Services

Veeva offers a suite of cloud applications and data services tailored to the life sciences sector. Core offerings include Veeva Vault for content and document lifecycle management used in regulatory submission workflows and Good Manufacturing Practice compliance; Veeva CRM for customer engagement supporting field teams interacting with institutions such as Mayo Clinic and Cleveland Clinic; and Veeva Clinical Suite for trial management integrated with vendors in the clinical research ecosystem like IQVIA and PPD. The company also provides data products that integrate with commercial datasets from providers such as IMS Health (now part of IQVIA), and connects with laboratory and supply chain partners including Thermo Fisher Scientific and GE Healthcare. Veeva’s professional services assist implementations alongside system integrators such as Deloitte, Accenture, and PwC.

Corporate Governance and Leadership

Veeva’s corporate governance structure comprises a board of directors and an executive team with experience in enterprise software and life sciences. The founder and CEO has been a public figure in the enterprise software community alongside peers from Salesforce and Oracle. The board has included executives and directors with backgrounds at Microsoft, Cisco Systems, and major pharmaceutical firms like Eli Lilly and Company. Veeva has engaged with investor constituencies that include Vanguard Group, BlackRock, and T. Rowe Price, aligning corporate strategy with institutional shareholder expectations. Governance matters interact with regulatory considerations overseen by agencies such as the Securities and Exchange Commission.

Financial Performance

Since its IPO, Veeva reported recurring revenue growth driven by subscription services and professional services engagements, comparable to other cloud vendors like Adobe Inc. and Autodesk. Financial metrics have been scrutinized by analysts at firms including Goldman Sachs, Morgan Stanley, and J.P. Morgan Chase. Revenue trends reflect adoption cycles among major clients such as Bristol Myers Squibb and Amgen, and have been influenced by macroeconomic factors monitored by institutions like the Federal Reserve and International Monetary Fund. Veeva’s balance sheet and cash flow profile have supported investment in R&D and selective acquisitions while navigating sector-specific reimbursement and regulatory headwinds exemplified in disputes involving companies like Theranos and regulatory reviews by Health Canada.

Market Position and Competitors

In the life sciences cloud market, Veeva competes with a mix of specialized vendors and large enterprise software firms. Competitors include niche providers such as Medidata Solutions (acquired by Dassault Systèmes), PAREXEL, and Oracle Health Sciences, as well as broader cloud incumbents like Microsoft Azure and Amazon Web Services when platform-level services intersect with vertical offerings. Strategic alliances and customer relationships differentiate market positioning versus rivals such as IQVIA and SS&C Technologies. Market share assessments are produced by analysts at Gartner and Forrester Research, and benchmarked against enterprise adoption patterns seen in sectors represented by companies like Siemens Healthineers and Philips.

Corporate Responsibility and Compliance

Veeva engages in corporate responsibility initiatives addressing data privacy, cybersecurity, and ethical practices linked to life sciences stakeholders including World Health Organization guidelines and ICH standards. Compliance programs align with legal frameworks such as the U.S. Foreign Corrupt Practices Act and the General Data Protection Regulation enforced by the European Commission. The company collaborates with clinical research networks, patient advocacy groups like Patient-Centered Outcomes Research Institute, and participates in industry consortia alongside organizations such as BIO and PhRMA. Corporate social responsibility reporting follows norms similar to those adopted by multinational peers including IBM and Cisco Systems.

Category:Software companies of the United States Category:Cloud computing providers